Advanced search
Publication Cover
The European Journal of Contraception & Reproductive Health Care Volume 19, 2014 - Issue 6
Submit an article Journal homepage
170
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan

Karmen S. Louie *Gynuity Health Projects, New York, NY, USACorrespondence[email protected]
,
Tamar TsereteliGynuity Health Projects, Tbilisi, Georgia
,
Erica Chong *Gynuity Health Projects, New York, NY, USA
,
Faiza AliyevaScientific Research Institute of Obstetrics and Gynaecology, Baku, Azerbaijan
,
Gulnara RzayevaScientific Research Institute of Obstetrics and Gynaecology, Baku, Azerbaijan
&
Beverly Winikoff *Gynuity Health Projects, New York, NY, USA
Pages 457-464 | Published online: 22 Jul 2014

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Sara Vodopivec, Eda Vrtacnik Bokal & Bojana Pinter. (2019) Counselling before first trimester abortion and acceptability of the procedure: results from a Slovenian cross-sectional study. The European Journal of Contraception & Reproductive Health Care 24:6, pages 487-493.
Read now
Tamar Tsereteli, Erica Chong, Karmen Louie, Zaza Bokhua & Beverly Winikoff. (2016) Acceptability and feasibility of 400 μg buccal misoprostol after 200 mg mifepristone for early medical abortion in Georgia. The European Journal of Contraception & Reproductive Health Care 21:5, pages 367-371.
Read now
Karmen S Louie, Erica Chong, Tamar Tsereteli, Gayane Avagyan, Susanna Vardanyan & Beverly Winikoff. (2014) The introduction of first trimester medical abortion in Armenia. Reproductive Health Matters 22:sup44, pages 56-66.
Read now

Articles from other publishers (11)

Katherine Gambir, Camille Garnsey, Kelly Ann Necastro & Thoai D Ngo. (2020) Effectiveness, safety and acceptability of medical abortion at home versus in the clinic: a systematic review and meta-analysis in response to COVID-19. BMJ Global Health 5:12, pages e003934.
Crossref
Ian Ferguson & Heather Scott. (2020) Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries. Journal of Obstetrics and Gynaecology Canada 42:12, pages 1532-1542.e2.
Crossref
Bushra Alam, Amy Kaler & Zubia Mumtaz. (2020) Women’s voices and medical abortions: A review of the literature. European Journal of Obstetrics & Gynecology and Reproductive Biology 249, pages 21-31.
Crossref
Katherine Gambir, Caron Kim, Kelly Ann Necastro, Bela Ganatra & Thoai D Ngo. (2020) Self-administered versus provider-administered medical abortion. Cochrane Database of Systematic Reviews 2020:3.
Crossref
Sarah Warden, Inna Genkin, Susan Hum & Sheila Dunn. (2019) Outcomes During Early Implementation of Mifepristone-Buccal Misoprostol Abortions up to 63 Days of Gestation in a Canadian Clinical Setting. Journal of Obstetrics and Gynaecology Canada 41:5, pages 647-652.
Crossref
Tsikouras Panagiotis. (2018) Comparative study for efficacy of termination in first trimester pregnancy using Misoprostol and Mifepristone. Archives of Community Medicine and Public Health, pages 038-046.
Crossref
K. Bettahar, A. Pinton, T. Boisramé, V. Cavillon, S. Wylomanski, I. Nisand & D. Hassoun. (2016) Interruption volontaire de grossesse par voie médicamenteuse. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 45:10, pages 1490-1514.
Crossref
Ingrida Platais, Tamar Tsereteli, Galina Grebennikova, Tatyana Lotarevich & Beverly Winikoff. (2016) Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10 weeks of pregnancy in Kazakhstan. International Journal of Gynecology & Obstetrics 134:3, pages 268-271.
Crossref
Erica Chong, Laura J. Frye, Jen Castle, Gillian Dean, Laurel Kuehl & Beverly Winikoff. (2015) A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.S.. Contraception 92:3, pages 215-219.
Crossref
Marji Gold & Erica Chong. (2015) If we can do it for misoprostol, why not for mifepristone? The case for taking mifepristone out of the office in medical abortion. Contraception 92:3, pages 194-196.
Crossref
Melissa J. Chen & Mitchell D. Creinin. (2015) Mifepristone With Buccal Misoprostol for Medical Abortion. Obstetrics & Gynecology 126:1, pages 12-21.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.